High prevalence of advanced colorectal neoplasia in the Thai population: A prospective screening colonoscopy of 1,404 cases

BMC Gastroenterology

Volumn 16, Issue 1, 2016, Pages

  Siripongpreeda, Bunchorn ^a   Mahidol, Chulabhorn ^a,b,c   Dusitanond, Navara ^a   Sriprayoon, Tassanee ^a   Muyphuag, Bunlung ^a   Sricharunrat, Thaniya ^a   Teerayatanakul, Narongchai ^a   Chaiwong, Watanya ^a   Worasawate, Wipra ^a   Sattayarungsee, Prassanee ^a   Sangthongdee, Juthamas ^a   Prarom, Jirapa ^a   Sornsamdang, Gaidganok ^a   Soonklang, Kamonwan ^a   Wittayasak, Kasiruck ^a   Auewarakul, Chirayu U ^a,c  

^a CHULABHORN GRADUATE INSTITUTE   (Thailand)

^b CHULABHORN RESEARCH INSTITUTE   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adenoma; Advanced colorectal neoplasia; Colorectal cancer; Fecal immunochemical test; National policy; Screening colonoscopy

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; COLON ADENOMA; COLON BIOPSY; COLON POLYPOSIS; COLON SURGERY; COLONOSCOPY; COLORECTAL CANCER; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; FEMALE; HEALTH PROGRAM; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THAI (PEOPLE); TUMOR LOCALIZATION; TUMOR VOLUME; VOLUNTEER; ADENOMA; CHEMISTRY; COLORECTAL NEOPLASMS; FECES; MASS SCREENING; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; THAILAND;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; FECES; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THAILAND;

EID: 84988353943     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/s12876-016-0526-0     Document Type: Article

References (49)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917.
2. Hospital based cancer registry National Cancer Institute of Thailand. 2002-2011. http://www.nci.go.th/en/cancer_record/cancer_rec1.html. Accessed 20 July 2012.
3. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-96.
4. Winawer SJ. The history of colorectal cancer screening: a personal perspective. Dig Dis Sci. 2015;60(3):596-608.
5. Friedrich K, Gruter L, Gotthardt D, Eisenbach C, Stremmel W, Scholl SG, et al. Survival in patients with colorectal cancer diagnosed by screening colonoscopy. Gastrointest Endosc. 2015;82(1):133-7.
6. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594-642.
7. Khuhaprema T, Sangrajrang S, Lalitwongsa S, Chokvanitphong V, Raunroadroong T, Ratanachu-ek T, et al. Organised colorectal cancer screening in Lampang Province, Thailand: preliminary results from a pilot implementation programme. BMJ Open. 2014;4(1):1-11.
8. Aniwan S, Rerknimitr R, Kongkam P, Wisedopas N, Ponuthai Y, Chaithongrat S, et al. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants. Gastrointest Endosc. 2015;81(3):719-27.
9. Lohsiriwat V. Accuracy of self-checked fecal occult blood testing for colorectal cancer in Thai patients. Asian Pac J Cancer Prev. 2014;15(18):7981-4.
10. Sobin LH, Wittekind C, M. G. TNM classification of malignant tumours (UICC S.). 7th ed. New York: Wiley-Blackwell 2009. p. 73-7.
11. Network NCC. NCCN Guidelines, Colorectal Cancer, Version I 2010. 2010.
12. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology. 1985;88(3):820-37.
13. Blebea J, McPherson RA. False-positive guaiac testing with iodine. Arch Pathol Lab Med. 1985;109(5):437-40.
14. Sung JJ, Lau JY, Young GP, Sano Y, Chiu HM, Byeon JS, et al. Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 2008;57(8):1166-76.
15. Bae T, Ha Y, Kim C, Lee J, Ha K, Shin S, et al. Distribution of the colonoscopic adenoma detection rate according to age: is recommending colonoscopy screening for koreans over the age of 50 safe? Ann Coloproctol. 2015;31(2):46-51.
16. Rerknimitr R, Ratanapanich W, Kongkam P, Kullavanijaya P. Differences in characteristics of colorectal neoplasm between young and elderly Thais. World J Gastroenterol. 2006;12(47):7684-9.
17. Aswakul P, Prachayakul V, Lohsiriwat V, Bunyaarunnate T, Kachintorn U. Screening colonoscopy from a large single center of Thailand - something needs to be changed? Asian Pac J Cancer Prev. 2012;13(4):1361-4.
18. Wisedopas N, Thirabanjasak D, Taweevisit M. A retrospective study of colonic polyps in King Chulalongkorn Memorial Hospital. J Med Assoc Thai. 2005;88 Suppl 4:S36-41.
19. Arayasakulwong N, Rojborwonwitaya J, Onnom K. Prevalence of colorectal adenomatous polyps in patients undergoing colonosopic examination at rajavithi hospital. Thai J Gastroenterol. 2009;10(1):9-15.
20. Srichan P, Wasutit Y, Suwanthanma W, Euanorasetr C, Sornmayura P, Puanfoong O, et al. Characteristic of mixed hyperplastic-adenomatous polyps at ramathibodi hospital. Thai J Surg. 2009;30:17-21.
21. Leggett BA, Devereaux B, Biden K, Searle J, Young J, Jass J. Hyperplastic polyposis: association with colorectal cancer. Am J Surg Pathol. 2001;25(2):177-84.
22. Hyman NH, Anderson P, Blasyk H. Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon Rectum. 2004;47(12):2101-4.
23. SEER Cancer Statistics Review, National Cancer Institute. 1975-2010. http://seer.cancer.gov/archive/csr/1975_2010/. Accessed 20 July 2012.
24. Young PE, Womeldorph CM. Colonoscopy for colorectal cancer screening. J Cancer. 2013;4(3):217-26.
25. Paskett ED, Khuri FR. Can we achieve an 80 % screening rate for colorectal cancer by 2018 in the United States? Cancer. 2015.
26. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med. 1996;334(3):155-9.
27. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014;160(3):171.
28. Giorgi Rossi P, Vicentini M, Sacchettini C, Di Felice E, Caroli S, Ferrari F, et al. Impact of screening program on incidence of colorectal cancer: a cohort study in Italy. Am J Gastroenterol. 2015;110(9):1359-66.
29. Saengow U, Chongsuwiwatvong V, Geater A, Birch S. Preferences and acceptance of colorectal cancer screening in Thailand. Asian Pac J Cancer Prev. 2015;16(6):2269-76.
30. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134(5):1570-95.
31. Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010;59(5):666-89.
32. Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2012;143(3):844-57.
33. Fairley KJ, Li J, Komar M, Steigerwalt N, Erlich P. Predicting the risk of recurrent adenoma and incident colorectal cancer based on findings of the baseline colonoscopy. Clin Transl Gastroenterol. 2014;5:e64.
34. Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, et al. Colorectal cancer screening, version 1.2015. J Natl Compr Canc Netw. 2015;13(8):959-68.
35. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008;359(12):1218-24.
36. Leung WK, Lau JY, Suen BY, Wong GL, Chow DK, Lai LH, et al. Repeat-screening colonoscopy 5 years after normal baseline-screening colonoscopy in average-risk Chinese: a prospective study. Am J Gastroenterol. 2009;104(8):2028-34.
37. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol. 2011;29(28):3761-7.
38. Chung SJ, Kim YS, Yang SY, Song JH, Kim D, Park MJ, et al. Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans. Gut. 2011;60(11):1537-43.
39. Shergill AK, Conners EE, McQuaid KR, Epstein S, Ryan JC, Shah JN, et al. Protective association of colonoscopy against proximal and distal colon cancer and patterns in interval cancer. Gastrointest Endosc. 2015;82(3):529-37. e1.
40. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2012;61(11):1576-82.
41. Itatsu K, Yokoyama Y, Ebata T, Igami T, Sugawara G, Uehara K, et al. The value of preoperative screening colonoscopies in patients with biliary tract cancer. J Gastroenterol. 2016;51(2):138-43.
42. Robertson DJ, Kaminski MF, Bretthauer M. Effectiveness, training and quality assurance of colonoscopy screening for colorectal cancer. Gut. 2015;64(6):982-90.
43. Ross WA, Thirumurthi S, Lynch PM, Rashid A, Pande M, Shafi MA, et al. Detection rates of premalignant polyps during screening colonoscopy: time to revise quality standards? Gastrointest Endosc. 2015;81(3):567-74.
44. Hassan C, Gralnek IM. Cost-effectiveness of "full spectrum endoscopy" colonoscopy for colorectal cancer screening. Dig Liver Dis. 2015;47(5):390-4.
45. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. J Am Med Assoc. 2006;295(20):2366-73.
46. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology. 2007;132(1):96-102.
47. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol. 2008;6(10):1117-21. quiz 064.
48. Singh H, Nugent Z, Demers AA, Bernstein CN. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010;105(12):2588-96.
49. Colorectal Cancer Facts & Figures 2014-2016. American Cancer Society, Atlanta. 2014. http://www.cancer.org/acs/groups/content/documents/document/acspc-042280.pdf. Accessed 8 Oct 2015.